| Title | Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice. |
| Publication Type | Journal Article |
| Year of Publication | 2016 |
| Authors | Sierksma, ASR, de Nijs, L, Hoogland, G, Vanmierlo, T, van Leeuwen, FW, Rutten, BPF, Steinbusch, HWM, Prickaerts, J, van den Hove, DLA |
| Journal | J Alzheimers Dis |
| Volume | 51 |
| Issue | 3 |
| Pagination | 677-82 |
| Date Published | 2016 |
| ISSN | 1875-8908 |
| Keywords | Alzheimer Disease, Amyloid beta-Protein Precursor, Animals, Anticonvulsants, Body Weight, Disease Models, Animal, Fluoxetine, Humans, Logistic Models, Male, Mice, Inbred C57BL, Mice, Transgenic, Neuroprotective Agents, Presenilin-1, Seizures |
| Abstract | Treatment of Alzheimer's disease (AD) patients with the antidepressant fluoxetine is known to improve memory and cognitive function. However, the mechanisms underlying these effects are largely unknown. To unravel these mechanisms, we aimed to treat APPswe/PS1dE9 mice with fluoxetine. Unexpectedly, with time, an increased number of animals displayed seizure behavior and died. Although spontaneous behavioral seizures have been reported previously in this mouse model, the observation of seizures and death consequential to fluoxetine treatment is new. Our results warrant further research on the underlying mechanisms as this may refine the treatment of AD patients. |
| DOI | 10.3233/JAD-151066 |
| Alternate Journal | J. Alzheimers Dis. |
| PubMed ID | 26890781 |
